|
Research & Education > Seminar
Series Schedule 2007
Seminar Series Schedule 2007
An annual Seminar Series is co-sponsored by the Institute for Hepatitis
and Virus Research (IHVR), the Hepatitis B Foundation, and the Drexel
Institute to promote scientific exchange at the national and international
level.
January 17 - Adam Zlotnick, PhD (Univ. of Oklahoma Health Sciences Center)
“HBV assembly as an antiviral target”
February 13 – Richard M. Carlton, PhD
“A mechanism for getting drugs for hepatitis or liver cancer tested and approved in China”
February 16 – David Perlman, PhD (Boston University School of Medicine)
“Biological insight through proteomics: lessons in hepadnaviral capsid dynamics, nitrite-induced cardioprotection, systemic amyloidoses and lymphomagenesis”
March 13 - 4:00 PM – Patrick J Kelly, PhD*
“How biotech companies can prepare for the IP component of venture capital due diligence”
April 10 - 4:00 PM - Stanley Lemon, MD (University of Texas Medical Branch)
“Confounding the host: Evasion of innate immune responses by hepatitis viruses”
April 17 - 4:00 PM - Ed Richman (CEO, Richman Chemicals, Inc)*
“Effective Outsourcing for Start Up Companies”
April 27 - 4:00 PM – Frank Chisari, MD (The Scripps research Institute)
“Determinants of viral persistence in hepatitis virus infection ”
April 30 - 11:00 AMRichard Rest, PhD (Drexel University College of Medicine)
“The road to understanding anthrax pathogenesis: Holes and Tolls”
May 17 - 4:00 PM – Carole Egan DeNatale (Woodcock Washburn, LLP)*
“Strategies for name selection and protection ”
May 21 - 11:00 AM – Uri Galili, PhD (University of Massachusetts Medical School)
"Increasing immunogenicity of viral and cancer vaccines by anti-Gal mediated targeting to APC”
July 12 - 11:00 AM – Andrew Talal, PhD (Weill Cornell Medical College)
“"Chemokines in chronically HCV-infected patients: inflammatory mediators and markers of treatment outcome" ”
July 20 - 11:00 AM – Hui Zhang, PhD (Johns Hopkins University)
“Identification of disease-associated glycopeptides as candidate biomarkers ”
August 30 - 11:00 AM - Rado Goldman, PhD (Georgetown University Medical Center)
"Detection of Hepatocellular Carcinoma: Peptides, Glycans, and Autoantibodies"
September 7 - 11:00 AM - Betsy M. Sutherland, PhD (Brookhaven National Laboratory)
"Repair of Clustered DNA Damages: oligonucleotides, human cells and tissue"
September 12 - 11:00 AM - Weidong Xiao, PhD (University of Pennsylvania School of Medicine)
"AAV vector as a gene transfer tool"
September 24 - 11:00 AM - Young Hann, PhD (University of Virginia)
"Role of HCV-mediated DC dysfunction in regulation of CD4+ T cell responses"
October 5 - 11:00 AM - Stephen Jennings, PhD (Drexel University College of Medicine)
"Cellular Immunity to Herpes Simplex Virus Infections: Implications for Latency and Reactivation"
October 11 -11:00 AM - Jorge Marrero, PhD (University of Michigan)
"Diagnosis and prognosis of hepatocellular carcinoma"
October 25 -11:00 AM - E. John Wherry, PhD (The Wistar Institute)
"Dysfunction and negative regulation of antiviral CD8 T cell responses during chronic infection"
November 9 -7:45 AM - 1:00 PM - Annual RBC Biotech Conference
"Biotech Success Stories: What Big and Small Companies are Looking For"
November 28 - 11:00 AM - David Thomas, MD (Johns Hopkins University School of Medicine)
"Pathogenesis of Chronic Viral Liver Disease In HIV Infected Persons"
December 7 - 11:00 AM - Michael Robek, PhD (Yale University School of Medicine)
"Manipulating the Host Immune Response to Inhibit HBV Replication"
|
